Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Chang L, Kang Y, Zhu M, Liu J, et al. Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation. PLoS One 2026;21:e0350571.
PMID: 42809552


Privacy Policy